LAKEWOOD, Colo. — Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”). GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and Peptide Synthesis solutions […]
Matthews, N.C. – CEM Corporation today announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, in-situ hybridization and particularly in the field of peptide synthesis. […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global leader in the development and manufacturing of Good Manufacturing Practices (GMP)-grade raw and ancillary reagents, announced a commitment to invest between $40 million and $50 million to expand its GMP-grade protein production capacity. This investment will fund a new facility that is specifically dedicated to supporting the […]
WASHINGTON — Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. The combined revenue of the businesses, which are part of Danaher’s Life Sciences segment, was approximately $140 million in 2018. Danaher […]
SHIRLEY, NY – As an excellent supplier and manufacturer, Creative Enzymes has recently upgraded several enzymes related services, such as enzyme expression and purification services, and enzyme engineering services, for researchers working in the life science or research field. After years of experience in serving companies and research institutes, Creative Enzymes has been proven the […]
Gardner, MA: New England Peptide, a leading provider of high-quality custom peptides and antibodies to the global life sciences market, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support the company’s worldwide growth initiatives, including fueling the expansion of peptide synthesis capabilities to better serve an […]
Cutting-edge technology for making proteins in a test tube now available to educators Cambridge, MA – Today, miniPCR bio™ launched BioBits™, an advanced synthetic biology system that can perform biological experiments without the need for living cells or specialized equipment. The BioBits™ system enables protein synthesis at very low cost, making it ideal for educational uses […]
BOULDER, Colo. — InDevR, Inc., a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, today announced that it has raised a $7 million Series A round of equity financing from Adjuvant Capital (“Adjuvant”). The investment from Adjuvant will support research and development activities and allow InDevR to build out a global […]
ANKENY, IA – Proliant Biologicals, LLC (Proliant), an LGI company (Lauridsen Group Inc.), today announced that it has acquired Boval BioSolutions from Lifecycle Biotechnologies of Fort Worth, TX. The acquisition concluded on September 2, 2019 and financial terms of the deal were not disclosed. According to Stephen Welch, President of Proliant, “Boval possesses proprietary technologies […]
MTAC application leverages Gibson Assembly® technology to advance automated protein and antibody engineering capabilities and custom vector printing SAN DIEGO–SGI-DNA announces the launch of the Multi-Tile Assembly Cloning (MTAC) application for its BioXp™ 3200 System, providing scientists with the ability to synthesize two genes and clone them with an optional constant fragment into their vector of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
